27968 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 23
12:14 UTC
|
KLC
KinderCare Learning Companies
|
◎ Target | Toni Kaplan ★★★☆☆ #1075 | Underweight | $2.50→ $2.00-20.0% |
|
Sep 23
12:14 UTC
|
KBH
KB Home
|
◎ Target | Rafe Jadrosich ★★★☆☆ #2071 | Neutral | $56.00→ $54.00-3.6% |
|
Sep 23
12:14 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★☆☆☆ #2474 | Overweight | $50.00→ $57.00+14.0% |
|
Sep 23
10:13 UTC
|
STAN
Standard Chartered
|
◎ Target | firm only | Neutral | GBX 2,230→ GBX 2,370+6.3% |
|
Sep 23
10:13 UTC
|
SMIN
Smiths Group
|
◎ Target | firm only | Buy | GBX 3,000→ GBX 3,200+6.7% |
|
Sep 23
10:13 UTC
|
SDLF
Standard Life
|
◎ Target | firm only | Sec→ r perform | GBX 885→ GBX 970+9.6% |
|
Sep 23
10:13 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Buy | GBX 840→ GBX 860+2.4% |
|
Sep 23
10:13 UTC
|
KGF
Kingfisher
|
◎ Target | firm only | Hold | GBX 295→ GBX 320+8.5% |
|
Sep 23
10:13 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,570→ GBX 1,640+4.5% |
|
Sep 23
10:13 UTC
|
HAS
Hays
|
◎ Target | firm only | Neutral | GBX 33→ GBX 65+97.0% |
|
Sep 23
10:13 UTC
|
BP
BP
|
◎ Target | firm only | Overweight | GBX 550→ GBX 675+22.7% |
|
Sep 23
10:13 UTC
|
BOKU
Boku
|
◎ Target | firm only | Buy | GBX 200→ GBX 210+5.0% |
|
Sep 23
10:13 UTC
|
BARC
Barclays
|
◎ Target | firm only | Neutral | GBX 510→ GBX 500-2.0% |
|
Sep 23
10:13 UTC
|
ABF
Associated British Foods
|
◎ Target | firm only | Sec→ r perform | GBX 1,550→ GBX 1,520-1.9% |
|
Sep 23
00:12 UTC
|
XMTR
Xometry
|
◎ Target | Scott Devitt ★★★☆☆ #1873 | Buy | $110.00→ $120.00+9.1% |
|
Sep 23
00:12 UTC
|
WBD
Warner Bros. Discovery
|
◎ Target | Sean Diffley ★★☆☆☆ #2406 | Equal Weight | $29.00→ $31.00+6.9% |
|
Sep 23
00:12 UTC
|
WAL
Western Alliance Bancorporation
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $98.00→ $95.00-3.1% |
|
Sep 23
00:12 UTC
|
VRDN
Viridian Therapeutics
|
◎ Target | Lisa Walter ★★☆☆☆ #2445 | Outperform | $36.00→ $38.00+5.6% |
|
Sep 23
00:12 UTC
|
TYRA
Tyra Biosciences
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $30.00→ $29.00-3.3% |
|
Sep 23
00:12 UTC
|
TWLO
Twilio
|
◎ Target | Catharine Trebnick ★★☆☆☆ #2359 | Buy | $275.00→ $290.00+5.5% |
|
Sep 23
00:12 UTC
|
TWLO
Twilio
|
◎ Target | Derrick Wood ★★★☆☆ #2003 | Buy | $260.00→ $300.00+15.4% |
|
Sep 23
00:12 UTC
|
TPB
Turning Point Brands
|
◎ Target | Ian Zaffino ★★★☆☆ #1267 | Outperform | $130.00→ $90.00-30.8% |
|
Sep 23
00:12 UTC
|
TCBI
Texas Capital Bancshares
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $107.00→ $104.00-2.8% |
|
Sep 23
00:12 UTC
|
TBTG
The Beauty Tech Group
|
◎ Target | firm only | Buy | GBX 545→ GBX 600+10.1% |
|
Sep 23
00:12 UTC
|
TA
TransAlta
|
◎ Target | firm only | C$26.00→ C$24.50-5.8% | |
|
Sep 23
00:12 UTC
|
SYK
Stryker
|
◎ Target | Mathew Blackman ★★★☆☆ #2072 | Hold | $355.00→ $298.00-16.1% |
|
Sep 23
00:12 UTC
|
STZ
Constellation Brands
|
◎ Target | Lauren Lieberman ★★☆☆☆ #2421 | Equal Weight | $132.00→ $122.00-7.6% |
|
Sep 23
00:12 UTC
|
STZ
Constellation Brands
|
◎ Target | Filippo Falorni ★★★☆☆ #1421 | Buy | $185.00→ $165.00-10.8% |
|
Sep 23
00:12 UTC
|
STAA
STAAR Surgical
|
◎ Target | Young Li ★☆☆☆☆ #2985 | Buy | $28.00→ $23.00-17.9% |
|
Sep 23
00:12 UTC
|
SOUN
SoundHound AI
|
◎ Target | James Fish ★★★☆☆ #1076 | Neutral | $7.00→ $6.00-14.3% |
|
Sep 23
00:12 UTC
|
SAA
M&C Saatchi
|
◎ Target | firm only | Buy | GBX 195→ GBX 175-10.3% |
|
Sep 23
00:12 UTC
|
RXST
RxSight
|
◎ Target | Young Li ★☆☆☆☆ #2985 | Hold | $6.50→ $5.75-11.5% |
|
Sep 23
00:12 UTC
|
RXST
RxSight
|
◎ Target | Craig Bijou ★★☆☆☆ #2269 | Underperform | $6.50→ $5.50-15.4% |
|
Sep 23
00:12 UTC
|
PTCT
PTC Therapeutics
|
◎ Target | Kristen Kluska ★★★☆☆ #1469 | Overweight | $130.00→ $137.00+5.4% |
|
Sep 23
00:12 UTC
|
PSKY
Paramount Skydance
|
◎ Target | Benjamin Swinburne ★★★★★ #233 | Overweight | $10.00→ $11.50+15.0% |
|
Sep 23
00:12 UTC
|
PRTH
Priority Technology
|
◎ Target | Vasundhara Govil ★★★☆☆ #1641 | Market Perform | $6.50→ $8.00+23.1% |
|
Sep 23
00:12 UTC
|
PB
Prosperity Bancshares
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $79.00→ $77.00-2.5% |
|
Sep 23
00:12 UTC
|
ONB
Old National Bancorp
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $31.00→ $30.00-3.2% |
|
Sep 23
00:12 UTC
|
OKTA
Okta
|
◎ Target | Patrick Colville ★★★☆☆ #1028 | Sec→ r Outperform | $165.00→ $190.00+15.2% |
|
Sep 23
00:12 UTC
|
OKTA
Okta
|
◎ Target | Shrenik Kothari ★★★☆☆ #1289 | Outperform | $185.00→ $200.00+8.1% |
|
Sep 23
00:12 UTC
|
NXT
Nextpower
|
◎ Target | Ben Kallo ★★★☆☆ #1052 | Outperform | $156.00→ $116.00-25.6% |
|
Sep 23
00:12 UTC
|
NAKA
KindlyMD
|
◎ Target | Fedor Shabalin ★★★☆☆ #978 | Buy | $11.00→ $13.00+18.2% |
|
Sep 23
00:12 UTC
|
MSTR
Strategy
|
◎ Target | Fedor Shabalin ★★★☆☆ #978 | Buy | $175.00→ $195.00+11.4% |
|
Sep 23
00:12 UTC
|
MSI
Motorola Solutions
|
◎ Target | James Fish ★★★☆☆ #1076 | Overweight | $530.00→ $531.00+0.2% |
|
Sep 23
00:12 UTC
|
MSFT
Microsoft
|
◎ Target | Brian Schwartz ★★★☆☆ #1509 | Outperform | $515.00→ $570.00+10.7% |
|
Sep 23
00:12 UTC
|
META
Meta Platforms
|
◎ Target | Brent Thill ★★★☆☆ #2224 | Buy | $710.00→ $875.00+23.2% |
|
Sep 23
00:12 UTC
|
LEN
Lennar
|
◎ Target | Jade Rahmani ★★★☆☆ #984 | Underperform | $85.00→ $75.00-11.8% |
|
Sep 23
00:12 UTC
|
LAD
Lithia Motors
|
◎ Target | Michael Ward ★★★☆☆ #1889 | Buy | $455.00→ $409.00-10.1% |
|
Sep 23
00:12 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Alex Thompson not yet tracked | Buy | $132.00→ $152.00+15.2% |
|
Sep 23
00:12 UTC
|
KMI
Kinder Morgan
|
◎ Target | Elvira Scotto ★★★☆☆ #2192 | Sec→ r Perform | $35.00→ $36.00+2.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.